Pharming Healthcare, Inc. has partnered with Invitae to offer sponsored, no-charge genetic testing and counseling for individuals who may carry a pathogenic variant in one of two genes known to be associated with Activated PI3K Delta Syndrome (APDS), a rare Primary Immunodeficiency.
The navigateAPDS testing program may help eliminate barriers to genetic testing and increase certainty in obtaining a correct diagnosis by enabling patients suspected of having APDS, and their family members, to have access to genetic testing and counseling.
Rare primary immunodeficiencies, congenital neutropenia, WHIM syndrome
X4 Pharmaceuticals, Inc. has partnered with Invitae to offer third-party sponsored genetic testing at no charge for individuals who may carry a genetic mutation known to be associated with congenital neutropenia. Primary immunodeficiencies are a group of inherited disorders of the immune system including congenital neutropenia and WHIM syndrome.
Estimate your out-of-pocket cost for Invitae tests related to a personal or family history of breast, ovarian, colorectal, or uterine cancer.
The amount shown above is an estimate of your out-of-pocket cost based upon the information you entered about your health insurance coverage. It is not a confirmation that the test has been authorized by your insurance provider. Your final cost may vary based upon your health plan design, deductible, co-insurance, and out-of-pocket limits. Learn More >
As part of Invitae’s dedication to making high-quality genetic testing affordable and accessible, we also offer a patient pre-pay option of $250. Learn More >
We could not determine an out-of-pocket estimate. Please contact us for assistance.